If you made any changes in Pure these will be visible here soon.

Personal profile


I currently work on the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). BADBIR is a large pharmacovigilance cohort designed to collect data reflecting true clinical practice for treatment of patients with moderate-severe psoriasis with biologic, small molecule and conventional systemic therapies in the UK and ROI. My role includes providing support and guidance for researchers using the BADBIR dataset. My research interests include using longitudinal analyses to investiagte the safety, utilisation, and effectiveness of therapies prescribed for the treatment of moderate-severe psoriasis.


During my undergraduate degree, I completed a year-long placement with GlaxoSmithKline's clinical trial unit at Addenbrooke's Hospital in Cambridge. I worked on three phase I studies utilising experimental pain models in healthy volunteers and two studies investigating pain mechanisms in patients with osteoarthritis (OA). The experimental pain studies included the use of quantitative sensory testing (QST). I subsequently used this methodology in my PhD to investigate the associations between pain intensity, or changes in pain following treatment, and altered pain processing in people with knee pain and/or knee OA. 

I completed my PhD with the Arthritis Research UK Epidemiology Unit in 2014. The training I received in epidemiology during my PhD helped me to decide to pursue a career within this field. I have been employed as a Research Associate for the BADBIR cohort since May 2014. 


My collaborations

Prof. Christopher Griffiths

Dr. Kathleen McElhone

Dr. Mark Lunt

Prof. Richard Warren

Prof. Darren Ashcroft

Prof. Adele Green

Memberships of committees and professional bodies

2018 - present: British Assocaition of Dermatologists (BAD) research sub-committee; Society for Investigative Dermatology (SID)

2017 - present: British Assocaition of Dermatologists (BAD)

2016 - present: UK Health Data Analytics Network (UK-HDAN)

2016 - 2017: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

2015 - present: International Society for Pharmacoepidemiology (ISPE)

2014 - present: British Assocaition of Dermatologists Biologics and Immunomodulators Register (BADBIR) Steering Committee

2012 - 2014: Osteoarthritis Research Society International (OARSI)


2010 - 2014: Ph.D. Medicine (The University of Manchester)

Title: Central and peripheral mechanisms of pain in clinical knee Osteoarthritis


2006 - 2010: B.Sc. (Hons) Pharmacology with Industrial Experience (The University of Manchester)

Degree classification 2:1


Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Areas of expertise

  • RL Dermatology
  • RM Therapeutics. Pharmacology

Research Beacons, Institutes and Platforms

  • Digital Futures
  • Institute for Data Science and AI


Dive into the research topics where Kayleigh Mason is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or